About This Event

Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Sean Bohen, President and Chief Executive Officer, rings the Closing Bell.